Back to resultsClinical Intervention Psychosis and Addiction (KLIPS)
Primary Purpose
Psychosis, Substance Abuse
Status
Unknown status
Phase
Early Phase 1
Locations
Germany
Study Type
Interventional
Intervention
Skills trainig for patients with dual diagnosis
regular treatment
Sponsored by
About this trial
This is an interventional treatment trial for Psychosis focused on measuring KLIPS
Eligibility Criteria
Inclusion Criteria:
- Schizophrenia
- Addiction
- Written statement of agreement
- Majority
Exclusion Criteria:
- Acute psychosis
- Further neuropsychiatric disorder
Sites / Locations
- LVR Clinic Cologne - Academic Clinic of the University of CologneRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Treatment
Control
Arm Description
Outcomes
Primary Outcome Measures
Substance use
Substance use
Substance use
Change in drug use motivation
Change in drug use motivation
Change in drug use motivation
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01411566
Brief Title
Clinical Intervention Psychosis and Addiction
Acronym
KLIPS
Official Title
Evaluation of an Integrative Therapeutic Concept for Schizophrenic Patients With Comorbid Substance Use Disorder
Study Type
Interventional
2. Study Status
Record Verification Date
February 2011
Overall Recruitment Status
Unknown status
Study Start Date
January 2011 (undefined)
Primary Completion Date
November 2011 (Anticipated)
Study Completion Date
December 2011 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
University of Cologne
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate an integrative therapeutic concept for schizophrenic patients with comorbid substance use disorder.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychosis, Substance Abuse
Keywords
KLIPS
7. Study Design
Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
122 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Treatment
Arm Type
Experimental
Arm Title
Control
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
Skills trainig for patients with dual diagnosis
Intervention Description
Skills trainig for patients with dual diagnosis
Intervention Type
Behavioral
Intervention Name(s)
regular treatment
Intervention Description
regular treatment
Primary Outcome Measure Information:
Title
Substance use
Time Frame
one year
Title
Substance use
Time Frame
3 months
Title
Substance use
Time Frame
6 months
Title
Change in drug use motivation
Time Frame
3 months
Title
Change in drug use motivation
Time Frame
6 months
Title
Change in drug use motivation
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Schizophrenia
Addiction
Written statement of agreement
Majority
Exclusion Criteria:
Acute psychosis
Further neuropsychiatric disorder
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joerg Daumann, PhD
Organizational Affiliation
University of Cologne
Official's Role
Study Chair
Facility Information:
Facility Name
LVR Clinic Cologne - Academic Clinic of the University of Cologne
City
Cologne
ZIP/Postal Code
51109
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joerg Daumann, PhD
Phone
+49 221 478
Ext
87113
Email
joerg.daumann@uk-koeln.de
First Name & Middle Initial & Last Name & Degree
Susanne Koenig, Diploma
12. IPD Sharing Statement
Learn more about this trial
Clinical Intervention Psychosis and Addiction
We'll reach out to this number within 24 hrs